{"version":"1.0","type":"link","title":"Methodological interpretation of subgroup analysis by histological subtype for perioperative toripalimab in resectable non-small-cell lung cancer.","author_name":"Gil-Sierra MD 외","author_url":"https://prs-insight.online/author/Gil-Sierra%20MD","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95353","thumbnail_width":1200,"thumbnail_height":630}